Nathan Griffin

Nathan Griffin

Auto-generated profile, based on publicly available information

Nathan Griffin

Department of Cell and Tissue Biology, University of California, San Francisco, CA, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2023 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
WSWeiqiang Sun
Weiqiang Sun
XZXuemin Zhang
Xuemin Zhang
YQYing Qiao
Ying Qiao
NGNathan Griffin
Nathan Griffin
HZHongxia Zhang
Hongxia Zhang
HLHui Liu
Hui Liu
Perfluorooctanoic acid (PFOA), a typical perfluoroalkyl group compound, has received worldwide attention due to its significant environmental toxicity. Following regulatory bans on the production and emission of PFOA, concerns have been raised about the potential health risks and the safety of novel perfluoroalkyl analogues. HFPO-DA (trade name Gen-X) and HFPO-TA are two perfluoroalkyl analogues known to be bioaccumulative, whose level of toxicity and whether they are safe alternatives to PFOA remain unclear. In the following study, the physiological and metabolic effects of exposure to PFOA and its novel analogues were explored in zebrafish using 1/3 LC50 (PFOA 100 μM, Gen-X 200 μM, HFPO-TA 30 μM). At the same LC50 toxicological effect, exposure to PFOA and HFPO-TA resulted in abnormal phenotypes such as spinal curvature, pericardial edema and aberrant body length, while Gen-X was little changed. Metabolically, PFOA, HFPO-TA and Gen-X all significantly increased total cholesterol in exposed zebrafish with PFOA and HFPO-TA also increasing total triglyceride levels. Transcriptome analysis showed that the number of differentially expressed genes in PFOA, Gen-X, and HFPO-TA treated conditions compared to control groups were 527, 572, and 3, 933, respectively. KEGG and GO analysis of differentially expressed genes revealed pathways and functions related to lipid metabolism as well as significant activation of the peroxisome proliferators-activated receptor (PPARs) pathway. Furthermore, RT-qPCR analysis identified significant dysregulation in the downstream target genes of PPARα, which is responsible for lipid oxidative catabolism, and the SREBP pathway, which is responsible for lipid synthesis. In conclusion, both perfluoroalkyl analogues HFPO-TA and Gen-X exhibit significant physiological and metabolic toxicity to aquatic organisms and their environmental accumulation should be closely regulated.

27 August 2016 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
KSKatherine A. Sanders
Katherine A. Sanders
MBMiles C. Benton
Miles C. Benton
RLRod A. Lea
Rod A. Lea
VMVicki E. Maltby
Vicki E. Maltby
SASusan Agland
Susan Agland
JLJeannette Lechner-Scott
Jeannette Lechner-Scott
Immunoactivation is less evident in secondary progressive MS (SPMS) compared to relapsing-remitting disease. MicroRNA (miRNA) expression is integral to the regulation of gene expression; determining their impact on immune-related cell functions, especially CD4+ T cells, during disease progression will advance our understanding of MS pathophysiology. This study aimed to compare miRNA profiles of CD4+ T cells from SPMS patients to healthy controls (HC) using whole miRNA transcriptome next-generation sequencing (NGS). Total RNA was extracted from CD4+ T cells and miRNA expression patterns analyzed using Illumina-based small-RNA NGS in 12 SPMS and 12 HC samples. Results were validated in a further cohort of 12 SPMS and 10 HC by reverse transcription quantitative polymerase chain reaction (RT-qPCR). The ten most dysregulated miRNAs identified by NGS were selected for qPCR confirmation; five (miR-21-5p, miR-26b-5p, miR-29b-3p, miR-142-3p, and miR-155-5p) were confirmed to be down-regulated in SPMS (p < 0.05). SOCS6 is targeted by eight of these ten miRNAs. Consistent with this, SOCS6 expression is up-regulated in SPMS CD4+ T cells (p < 0.05). This is of particular interest as SOCS6 has previously been shown to act as a negative regulator of T cell activation. Ninety-seven percent of miRNA candidates identified by NGS were down-regulated in SPMS. The down-regulation of miRNAs and increased expression of SOCS6 in SPMS CD4+ T cells may contribute to reduced immune system activity in progressive MS.

1 March 2022 in Toxicology Letters
Verified
Journal Article
Closed access
HLHui Liu
Hui Liu
WSWeiqiang Sun
Weiqiang Sun
YZYongbing Zhou
Yongbing Zhou
NGNathan Griffin
Nathan Griffin
SFSam Faulkner
Sam Faulkner
LWLi Wang
Li Wang

1 September 2020 in The American Journal of Pathology
Verified
Journal Article
Closed access
NGNathan Griffin
Nathan Griffin
CRChristopher W. Rowe
Christopher W. Rowe
FGFangfang Gao
Fangfang Gao
PJPhillip Jobling
Phillip Jobling
VWVanessa Wills
Vanessa Wills
Hubert HondermarckHubert Hondermarck
Hubert Hondermarck

1 September 2020 in The American Journal of Pathology
Verified
Journal Article
Closed access
FGFangfang Gao
Fangfang Gao
NGNathan Griffin
Nathan Griffin
SFSam Faulkner
Sam Faulkner
XLXiang Li
Xiang Li
SKSimon J. King
Simon J. King
Hubert HondermarckHubert Hondermarck
Hubert Hondermarck

1 June 2021 in Pathology
Verified
Journal Article
Closed access
NGNathan Griffin
Nathan Griffin
FGFangfang Gao
Fangfang Gao
PJPhillip Jobling
Phillip Jobling
COChristopher Oldmeadow
Christopher Oldmeadow
VWVanessa Wills
Vanessa Wills
Hubert HondermarckHubert Hondermarck
Hubert Hondermarck